BRIEF published on 10/28/2025 at 21:20, 1 month 7 days ago Amrize Posts Robust Q3 2025 Results Amid Market Expansion Adjusted EBITDA Revenue Growth Financial Guidance Quarter Results Free Cash Flow
PRESS RELEASE published on 10/28/2025 at 21:15, 1 month 7 days ago Amrize Delivers Strong Third Quarter Revenue Growth and Free Cash Flow Generation Amrize reports strong revenue growth and free cash flow generation in Q3 2025 driven by infrastructure demand and market improvements Financial Results Revenue Growth Free Cash Flow Q3 2025 Amrize
BRIEF published on 10/09/2025 at 17:05, 1 month 26 days ago Amrize to Announce Q3 2025 Financial Results Financial Results Webcast Amrize Third Quarter 2025 Construction Markets
PRESS RELEASE published on 10/09/2025 at 17:00, 1 month 26 days ago Amrize Announces Date for Third Quarter 2025 Financial Results Amrize Ltd to announce third quarter 2025 financial results on October 28, 2025, followed by live webcast on October 29, 2025. Details at www.amrize.com/investors Financial Results Investors Webcast Third Quarter Amrize Ltd
BRIEF published on 08/28/2025 at 22:50, 3 months 7 days ago Amrize Advises Against TRC Capital's Mini-Tender Offer Shareholders Market Value Amrize Mini-Tender Offer TRC Capital
PRESS RELEASE published on 08/28/2025 at 22:45, 3 months 7 days ago Amrize Recommends Shareholders Reject Mini-Tender Offer By TRC Capital Investment Corporation Amrize recommends shareholders reject mini-tender offer by TRC Capital Investment Corporation due to below-market price for ordinary shares. Shareholders cautioned about SEC rules Shareholders Amrize Mini-Tender Offer TRC Capital SEC Rules
BRIEF published on 08/06/2025 at 22:20, 3 months 29 days ago Amrize Shows Steady Performance in Q2 2025 Amid Challenging Conditions Financial Results Market Position Growth Investment Financial Stability ASPIRE Program
PRESS RELEASE published on 08/06/2025 at 22:15, 3 months 29 days ago Amrize Delivers Solid Second Quarter, Starts Journey in Position of Strength Amrize delivers solid second quarter results showing strength in business and market positions. Launches ASPIRE program for synergies and accelerates margin expansion Financial Results Market Growth Amrize ASPIRE Program Investment-grade Balance Sheet
BRIEF published on 07/21/2025 at 20:05, 4 months 14 days ago Amrize to Release Q2 2025 Financial Results on August 6 Financial Results Webcast NYSE Q2 2025 Amrize
PRESS RELEASE published on 07/21/2025 at 20:00, 4 months 14 days ago Amrize Announces Date for Second Quarter 2025 Financial Results Amrize Ltd to reveal Q2 2025 financial results on August 6, 2025, followed by a webcast on August 7, 2025. Details at www.amrize.com/investors Financial Results Investors Webcast Q2 2025 Amrize Ltd
Published on 12/05/2025 at 02:35, 1 hour 59 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 3 hours 34 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 5 hours 29 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 5 hours 34 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 1 hour 3 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 4 hours 43 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 8 hours 8 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 8 hours 19 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 9 hours 23 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 10 hours 34 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 10 hours 49 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 10 hours 49 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 21 hours 33 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 10 hours ago Declaration of voting rights at the end of November 2025
